Skip to Main Content

HCV-TARGET- Hepatitis C Therapeutic Registry and Research Network

Conditions

Hepatitis | Diseases of the Digestive System - Liver

What is the purpose of this trial?

Aims of HCV-TARGET

  1. Utilize common NIH-supported data collection platform (REDCap) that will allow us to target specific questions described above
  2. Rapidly accrue and evaluate a large number of patients in "real world" treatment setting that includes well established community interface
  3. Rapidly recognize and respond to changing treatment paradigms and unmet needs.
  4. Utilize NIH CTSA research infrastructure in a "hub and spoke" model that will include community-based treating physicians
  5. Develop a large biorepository of prospectively collected samples that can interface with the NIH-CTSA translational research infrastructure
  • Trial with
    University of North Carolina at Chapel Hill
  • Start Date
    07/02/2014
  • End Date
    07/21/2020
Trial Image

For more information about this study, contact:

Hong Chau

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8348

  • Last Updated
    06/22/2018
  • Study HIC
    #1204010018